Risultati di ricerca
Johnson & Johnson is restoring the true meaning of healthcare by developing advanced treatments and smarter and less invasive solutions for today’s most complex diseases.
2 giorni fa · At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 135 years, we have aimed to keep people well at every age and every stage of life.
5 giorni fa · Johnson & Johnson Medical in Italia. Le società del Gruppo Johnson & Johnson operanti nel settore dei dispositivi medici sono impegnate a migliorare la salute delle persone ed elevare costantemente lo standard di cura.
4 giorni fa · Explore all Johnson & Johnson published press releases by date and/or topic of news.
28 mag 2024 · The Company1 enters agreement with Numab Therapeutics to acquire its wholly owned subsidiary2 for the global rights to NM26, a Phase 2-ready investigational, first-in-class bispecific antibody targeting two clinically proven pathways in atopic dermatitis (AD)
28 mag 2024 · Johnson & Johnson on Tuesday agreed to acquire the rights to an experimental skin disorder treatment from privately held Numab Therapeutics for about $1.25 billion, its second deal for an...
28 mag 2024 · Johnson & Johnson agreed to pay $1.25 billion for the rights to an experimental eczema treatment, the latest big pharma deal for a new type of drug that hits two biological targets at the...
